World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
39643
World Ranking
15371
National Ranking
1413

Psychology

D-Index
81
Citations
38633
World Ranking
1356
National Ranking
161

Stuart Montgomery publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Stuart Montgomery sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 462 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Stuart Montgomery D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Stuart Montgomery sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 81 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Stuart Montgomery is affiliated with Imperial College London in the United Kingdom. Their research primarily focuses on the treatment of major depression, incorporating genetic and pharmacological perspectives within psychiatry and mental health.

Their work spans across various fields of study, including medicine, pharmacology, psychiatry and mental health, experimental and cognitive psychology, biological psychiatry, and genetics. This multidisciplinary approach is reflected in their substantial publication record.

Montgomery's research topics cover:

  • Treatment of Major Depression
  • Tryptophan and brain disorders
  • Bipolar Disorder and Treatment
  • Mental Health Research Topics
  • Genetic Associations and Epidemiology
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Schizophrenia research and treatment

Their recent papers include:

  • Identifying the Common Genetic Basis of Antidepressant Response, 2021, Biological Psychiatry Global Open Science
  • Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping, 2020, Translational Psychiatry
  • A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response, 2021, European Neuropsychopharmacology
  • Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database, 2023, Journal of Affective Disorders

Montgomery frequently publishes in the following venues:

  • European Neuropsychopharmacology
  • Journal of Affective Disorders
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neuroscience Applied

Frequent co-authors who have collaborated extensively with Montgomery include:

  • Alessandro Serretti
  • Daniel Souery
  • Joseph Zohar
  • Chiara Fabbri
  • Julien Mendlewicz

Best Publications

  • A new depression scale designed to be sensitive to change.

    Stuart A. Montgomery;Marie Åsberg

  • A comprehensive psychopathological rating scale.

    M. Åsberg;S. A. Montgomery;C. Perris;D. Schalling

  • Social functioning in depression: a review

    Robert M.A. Hirschfeld;Stuart A. Montgomery;Martin B. Keller;Siegfried Kasper

  • Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

    Daniel Souery;Pierre Oswald;Isabelle Massat;Ursula Bailer

  • Treatment resistant depression: methodological overview and operational criteria.

    D. Souery;J. Amsterdam;C. de Montigny;Y. Lecrubier

  • Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey

    Hans-Ulrich Wittchen;R. M. Carter;H. Pfister;S. A. Montgomery

  • Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder

    Martin Keller;Stuart Montgomery;William Ball;Mary Morrison

  • Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia

    Stefano Pini;Giovanni B Cassano;Elisa Simonini;Mario Savino

  • A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?

    Connie Sanchez;Elin H. Reines;Stuart A. Montgomery

  • The prophylactic efficacy of fluoxetine in unipolar depression.

    S A Montgomery;H Dufour;S Brion;J Gailledreau

  • Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates

    Montgomery Sa;Henry J;McDonald G;Dinan T

  • The role of noradrenaline and selective noradrenaline reuptake inhibition in depression

    Nicoletta Brunello;Julien Mendlewicz;Siegfried Kasper;Brian Leonard

  • Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction

    S.A Montgomery;D.S Baldwin;A Riley

  • Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study.

    S. A. Montgomery;S. H. Kennedy;G. D. Burrows;M. Lejoyeux

  • Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.

    Stuart A Montgomery;L J Thal;R Amrein

  • Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.

    Stuart A. Montgomery;Kathy Tobias;Gwen L. Zornberg;Siegfried Kasper

  • Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.

    Robert M A Hirschfeld;Stuart A. Montgomery;Eugenio Aguglia;Mario Amore

  • Pharmacological prevention of suicidal behaviour.

    Stuart A. Montgomery;Deirdre Montgomery

  • Which antidepressants have demonstrated superior efficacy? A review of the evidence.

    Stuart A. Montgomery;David S. Baldwin;Pierre Blier;Naomi A. Fineberg

  • Humanistic and economic burden of generalized anxiety disorder in North America and Europe

    Dennis A. Revicki;Karin Travers;Kathleen W. Wyrwich;Henrik Svedsäter

  • A Randomised Study Comparing Escitalopram with Venlafaxine XR in Primary Care Patients with Major Depressive Disorder

    S.A. Montgomery;A.K.T. Huusom;J. Bothmer

Frequent Co-Authors

Siegfried Kasper
Siegfried Kasper Medical University of Vienna
Julien Mendlewicz
Julien Mendlewicz Université Libre de Bruxelles
Alessandro Serretti
Alessandro Serretti Kore University of Enna
Joseph Zohar
Joseph Zohar Sheba Medical Center
Raffaella Calati
Raffaella Calati University of Milano-Bicocca
Dan Rujescu
Dan Rujescu Medical University of Vienna
Gianluigi Forloni
Gianluigi Forloni Mario Negri Institute for Pharmacological Research
David S. Baldwin
David S. Baldwin University of Southampton
Cathryn M. Lewis
Cathryn M. Lewis King's College London
Michael E. Thase
Michael E. Thase University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in psychology opens doors to a variety of online programs and diverse career paths. Many students are interested in specialized roles such as becoming a marriage and family therapist (MFT). It's important to understand that MFT education and certification requirements can vary across different states and cities in the USA.

For example, if you want to learn about Aurora mft education requirements, you'll find that a master's degree in counseling or a related field is typically essential. Meanwhile, researching Austin mft certification requirements shows the importance of supervised clinical experience and passing relevant exams.

If you’re interested in other locations, you can explore specific steps on how to become a marriage and family therapist in Bakersfield, or review the Baltimore mft education requirements for more details.

By choosing the right online degree and understanding your state’s licensure process, you can embark on a meaningful career supporting individuals and families as a professional therapist.

Best Scientists Citing Stuart Montgomery

Trending Scientists

Recently Published Articles